Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
CytoDyn Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CYDY
Over the counter
8731
https://www.cytodyn.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for CytoDyn Inc
CytoDyn Announces FDA Has Lifted Clinical Hold
- Feb 29th, 2024 1:30 pm
CytoDyn Announces Submission of Clinical Protocol to FDA and Initiation of Pre-Clinical Study in Glioblastoma
- Feb 1st, 2024 1:30 pm
CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO
- Jan 29th, 2024 1:30 pm
CytoDyn Announces Webcast to Provide Company Update
- Dec 7th, 2023 9:00 pm
CytoDyn Appoints Jacob Lalezari M.D. as Interim CEO
- Nov 21st, 2023 1:30 pm
November 2023 Letter to Shareholders
- Nov 3rd, 2023 8:02 pm
CytoDyn Announces Company Updates and Investment Community Update Webcast
- Jul 11th, 2023 8:05 pm
CytoDyn Announces President Takes Medical Leave of Absence
- May 24th, 2023 9:05 pm
Scroll